While the effects of TRPV1 on anxiety and depression may be related to cannabinoid 1 (CB1) receptor interactions (Sartim et al., 2017) and regulation of the glutamate/NMDA pathway (Lisboa and Guimarães, 2012). The gene discussed is TRPV1; the disease is depressive symptom measurement.